| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |